-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

509. Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital: Poster II

Symposia: Bone Marrow Failure and Cancer Predisposition Syndromes: Congenital Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Stefano Giardino, MD1*, Dirk-Jan Eikema2,3*, Brian Piepenbroek4*, Mattia Algeri, MD5*, Mouhab Ayas, MD6, Maura Faraci, MD7*, Abdelghani Tbakhi, MD8*, Marco Zecca, MD9*, Mohammed Essa10*, Bénédicte Neven, MD, PhD11*, Yves Bertrand, MD, PhD12*, Gaurav Kharya13*, Tatiana A Bykova, MD, PhD14*, Sarah Lawson, MBBS FRCPath15*, Mario Petrini16, Alexander Mohseny17*, Fanny Rialland, MD18*, Beki James19*, Anca Colita, MD20*, Mony Fahd, MD MSc21*, Simone Cesaro, MD22*, Ansgar Schulz, MD23*, Carlo Dufour, MD24, Antonio M Risitano, MD, PhD25,26 and Regis Peffault De Latour27*

1Unità di Trapianto di Cellule Staminali Emopoietiche - Dipartimento di Ematologia, Oncologia e Trapianto di Cellule Staminali Emopoietiche, IRCCS Istituto Giannina Gaslini, Genova, Italy
2LUMC, Dept. Medical Statistics & Bioinformatics, Leiden, Netherlands
3EBMT Statistical Unit, Leiden, Netherlands
4EBMT Leiden Study Unit, Leiden, Netherlands
5Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Lazio, Italy
6Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Middle, Saudi Arabia
7Unità di Trapianto di Cellule Staminali Emopoietiche - Department of Hematology, Oncology and Hematopoietic Stem Cell Transplantion, IRCSS, Istituto Giannina Gaslini, Genova, Italy
8King Hussein Cancer Centre, Amman, Jordan
9Pediatric Hematology/Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
10Ministry of National Guard Health Affairs, King Abdulaziz Medical City, Riyadh, SAU
11Pediatric Immunology, Hematology and Rheumatology Unit, Hôpital Necker-Enfants Malades, AP-HP, Paris, France
12Unité de coordination interne et externe, Institut d`Hematologie et d`Oncologie Pediatrique, Lyon, France
13Indraprastha Apollo Hospitals, New Delhi, India
14RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation
15Birmingham Children's Hospital, Birmingham, United Kingdom
16Azienda Ospedaliero Universitaria Pisana, Department of Clinical and Experimental Medicine, Hematology, Pisa, Italy
17Division of stem cell transplantation, Willem-Alexander Children’s Hospital, Leiden University Medical Center, Leiden, Netherlands
18Service Onco-Hématologie Pédiatrique, Hôpital Mère-Enfant, Nantes University Hospital, Nantes, France
19Leeds Children's Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
20Fundeni Clinical Institute, University of Medicine Carol Davila, Bucharest, ROU
21Pediatric Hematology and Immunology Department, Robert-Debré Hospital, GH APHP Nord Université de Paris, Paris, France
22Pediatric Hematology-Oncology, Ospedale della Donna e del Bambino, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
23Department of Pediatrics, University Medical Center, Ulm, Germany
24Department of Hemato-Oncology,, Hematology Unit, IRCCS G. Gaslini Children's Hospital, Genova, Italy
25Hematology and Hematopoietic Transplantation, AORN S. Giuseppe Moscati Avellino, Avellino, Italy
26Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
27Hematology and Transplantation Unit, Hôpital Saint Louis, AP-HP, Paris, France

Masanori Yoshida, MD, PhD1*, Felicia Andresen, MD2, Hermann Yang3*, Sara Lewis, MS, CGC4*, Miriam Erlacher, MD, PhD2,5*, Dirk Lebrecht, PhD2*, Akiko Shimamura, MD, PhD3*, Charlotte M. Niemeyer2,5, Sushree S Sahoo, PhD1 and Marcin W. Wlodarski, MD, PhD1,6

1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
2Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
3Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA
4Department of Hematology, St Jude Children's Research Hospital, Lakeland, TN
5German Cancer Consortium (DKTK), Heidelberg, Germany
6University of Freiburg, Freiburg, Germany

Sarada Ketharnathan, PhD1, Sergey V Prykhozhij, PhD1*, Anna Cordeiro, PhD2, Yigal Dror, MD, FRCPC3,4 and Jason N. Berman, MD5

1CHEO Research Institute, Ottawa, ON, Canada
2AGADA Biosciences, Halifax, NS, Canada
3Institute of Medical Science, University of Toronto, Toronto, ON, Canada
4Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada
5Department of Pediatrics, CHEO Research Institute, Ottawa, ON, Canada

Narasaiah Kovuru, PhD1, Greer Jeffery, BA1*, Theresa Menna, BS1*, Yuning Hong, PhD2*, Zhe Zhang, PhD3*, Makiko Mochizuki Kashio, PhD4* and Peter Kurre, MD5

1Comprehensive Bone Marrow Failure Center, Department of Pediatrics, Children's hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia
3Biostatistics and Bioinformatics Core, Gene Therapy Program, University of Pennsylvania, Philadelphia, PA
4Department of Microscopic and Developmental Anatomy, Tokyo Women’s Medical University, Tokyo., Japan
5Comprehensive Bone Marrow Failure Center, Children's hospital of Philadelphia, Philadelphia, PA

Juraj Kokavec, PhD1*, Jan Procházka, PhD2*, Tomas Stopka, MD, PhD1 and Radislav Sedlacek, PhD2*

1BIOCEV, First Faculty of Medicine, Charles University, Prague, Czech Republic
2Czech Centre for Phenogenomics (BIOCEV / IMG), Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

Clarissa Gervasoni1*, Alice Martina Giussani, PhD Student1*, Nadia Bertola, PhD Student2*, Erica Dander, PhD1*, Andrea Biondi, MD1,3, Paola Corti, MD3*, Piero Farruggia, MD4*, Giuseppe Menna, MD5*, Marco Cipolli, MD6*, Valentino Bezzerri, PhD6*, Anna Pegoraro, MD6*, Simone Cesaro, MD7*, Carlo Dufour, MD8, Enrico Cappelli, MD9*, Silvia Ravera, PhD2* and Giovanna D'Amico, BSc, PhD, MSc1*

1Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, Italy
2Department of Experimental Medicine, University of Genoa, Genoa, Italy
3Pediatric Hemato-Oncolgy, Fondazione MBBM/ASST-Monza, University of Milano-Bicocca, Monza, Italy
4Pediatric Hematology and Oncology Unit, A.R.N.A.S. Ospedale Civico, Palermo, Italy
5Pediatric Hemato-Oncology Unit, Santobono-Pausilipon Hospital, Naples, Italy
6Cystic Fibrosis Center, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
7Pediatric Hematology-Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
8Department of Hemato-Oncology,, Hematology Unit, IRCCS G. Gaslini Children's Hospital, Genova, Italy
9Hematology Unit, IRCCS G. Gaslini Children's Hospital, Genoa, Italy

Brynn B Duncan, MD1,2*, Jennifer Lotter, PA-C3*, Jeanine Superata, RN3*, Ma Evette Barranta, BS4*, Ivana Darden, RN3*, Sanjay Venugopal4*, Colin O. Wu, PhD5*, Cynthia E. Dunbar, MD6 and David J. Young, MD, PhD3

1Pediatric Oncology Branch, NCI, Bethesda, MD
2Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health (NHLBI/NIH), Bethesda, MD
3Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
4Office of the Clinical Director, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
6Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda

Nidhi Aggarwal, BS1, Xiaoyang Ma, MS2*, Fernanda Gutierrez-Rodrigues, PhD3, Ruba Shalhoub, MS2*, Ivana Darden, RN1*, Bhavisha A. Patel, MD1, Colin O. Wu, PhD2*, Neal S. Young, MD1 and Emma M. Groarke, MD1

1Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
2Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3Hematology Branch, National Heart, Lung, and Blood Institute, National Institute of Health, Bethesda, MD

Anne Olazabal Herrero1,2, Fengshan Liang, PhD3*, Arijit Dutta, PhD4*, Yuxin Huang, PhD4*, Zhuobin Liang, PhD5*, Abhishek K Gupta, PhD3*, Li Lan6*, Manoj M Pillai, MD3, Patrick Sung, PhD7* and Gary M. Kupfer, MD8

1Department of Oncology, Georgetown University, Washington, DC
2Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
3Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT
4Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX
5Institute of Molecular Physiology, Shenzhen, China
6Harvard Medical School, Boston, MA
7Department of Biochemistry and Structural Biology, University of Texas Health Sciences Center San Antonio, San Antonio, TX
8Department of Oncology, Georgetown University, washington, DC

*signifies non-member of ASH